SHPPF Dividend: Redcare Pharmacy NV Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

SHPPF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2,820	2,370	1,798	1,204	1,060	968
Revenue Growth (YoY)	27%	32%	49%	14%	10%	38%
Cost of Revenue	2,175	1,824	1,358	872	793	748
Gross Profit	645	545	440	331	266	219
Selling, General & Admin	678	516	390	345	305	204
Research & Development	--	--	--	--	--	--
Operating Expenses	677	584	448	385	332	220
Other Non Operating Income (Expenses)	--	-8	5	-7	-6	-4
Pretax Income	-43	-47	-14	-84	-77	-15
Income Tax Expense	-7	-1	-2	-6	-3	0
Net Income	-35	-45	-12	-77	-74	-16
Net Income Growth	46%	275%	-84%	4%	363%	-56%
Shares Outstanding (Diluted)	20.8	20.05	19.23	18	17.9	14.4
Shares Change (YoY)	2%	4%	7%	1%	24%	10%
EPS (Diluted)	-1.69	-2.26	-0.62	-4.32	-4.15	-1.17
EPS Growth	41%	262%	-86%	4%	254.99%	-57.99%
Free Cash Flow	-61	-20	23	-82	-31	-35
Free Cash Flow Per Share	-2.93	-0.99	1.19	-4.55	-1.73	-2.43
Gross Margin	22.87%	22.99%	24.47%	27.49%	25.09%	22.62%
Operating Margin	-1.13%	-1.6%	-0.38%	-4.4%	-6.13%	-0.1%
Profit Margin	-1.24%	-1.89%	-0.66%	-6.39%	-6.98%	-1.65%
Free Cash Flow Margin	-2.16%	-0.84%	1.27%	-6.81%	-2.92%	-3.61%
EBITDA	36	30	50	-14	-39	15
EBITDA Margin	1.27%	1.26%	2.78%	-1.16%	-3.67%	1.54%
D&A For EBITDA	68	68	57	39	26	16
EBIT	-32	-38	-7	-53	-65	-1
EBIT Margin	-1.13%	-1.6%	-0.38%	-4.4%	-6.13%	-0.1%
Effective Tax Rate	16.27%	2.12%	14.28%	7.14%	3.89%	0%